As the world grapples with issues such as antibiotic resistance and the need for antiviral therapies in the wake of global pandemics, research into new APIs remains a priority. Collaborative efforts between academia, industry, and governments are crucial in fostering innovation and addressing unmet medical needs.
Regulatory agencies, including the Environmental Protection Agency (EPA) and the World Health Organization (WHO), have established guidelines and permissible levels for acrylamide in drinking water. Effective monitoring of water sources helps in identifying and managing acrylamide concentrations, thus mitigating potential risks associated with prolonged exposure. Continued research is essential to develop new treatment methods that minimize acrylamide formation during industrial applications while maintaining water quality.